ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,291.44
0.36%
Dow Jones
44,632.67
0.76%
Gold vs US Dollar
2,631.885
-3.07%
Brent Oil
73.04
-2.31%
Bitcoin
95,977.16
-2.11%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MiroMatrix Medical Inc (MIRO)

  7. MiroMatrix Medical Inc (MIRO) News

MiroMatrix Medical (MIRO)

MiroMatrix Medical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MIRO
DateTimeSourceHeadlineSymbolCompany
26/12/202311:02Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:MIROMiroMatrix Medical Inc
18/12/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIROMiroMatrix Medical Inc
18/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MIROMiroMatrix Medical Inc
13/12/202321:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202321:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202321:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202321:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202321:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202315:14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MIROMiroMatrix Medical Inc
13/12/202315:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MIROMiroMatrix Medical Inc
13/12/202315:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MIROMiroMatrix Medical Inc
13/12/202315:03Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MIROMiroMatrix Medical Inc
13/12/202314:15Business WireUnited Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerNASDAQ:MIROMiroMatrix Medical Inc
12/12/202316:22Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MIROMiroMatrix Medical Inc
12/12/202311:00Business WireUnited Therapeutics and Miromatrix Medical Announce Successful Tender OfferNASDAQ:MIROMiroMatrix Medical Inc
07/12/202321:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MIROMiroMatrix Medical Inc
30/11/202322:14Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MIROMiroMatrix Medical Inc
14/11/202321:05GlobeNewswire Inc.Miromatrix Reports Third Quarter 2023 ResultsNASDAQ:MIROMiroMatrix Medical Inc
14/11/202321:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MIROMiroMatrix Medical Inc
13/11/202312:01Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:MIROMiroMatrix Medical Inc
30/10/202311:03Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MIROMiroMatrix Medical Inc
30/10/202310:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIROMiroMatrix Medical Inc
30/10/202310:05GlobeNewswire Inc.United Therapeutics to Acquire Miromatrix MedicalNASDAQ:MIROMiroMatrix Medical Inc
30/10/202310:00Business WireUnited Therapeutics to Acquire Miromatrix MedicalNASDAQ:MIROMiroMatrix Medical Inc
11/10/202320:05GlobeNewswire Inc.Miromatrix to Present at the 2023 ISODP Organ Donation CongressNASDAQ:MIROMiroMatrix Medical Inc
05/10/202320:30GlobeNewswire Inc.Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the MesaNASDAQ:MIROMiroMatrix Medical Inc
06/09/202320:01GlobeNewswire Inc.Miromatrix Announces Participation in H.C. Wainwright Global Investment ConferenceNASDAQ:MIROMiroMatrix Medical Inc
05/09/202320:04GlobeNewswire Inc.Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics WorkshopNASDAQ:MIROMiroMatrix Medical Inc
14/08/202320:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MIROMiroMatrix Medical Inc
14/08/202320:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIROMiroMatrix Medical Inc
 Showing the most relevant articles for your search:NASDAQ:MIRO

Your Recent History

LSE
VAST
Vast Resources
LSE
GWMO
Great Western Mining
LSE
POS
Plexus
LSE
ITV
Itv
LSE
SYME
Supply@me Capital
LSE
MTRO
Metro Bank
LSE
TW.
Taylor Wimpey
LSE
HOC
Hochschild Mining
LSE
QED
Quadrise
LSE
SCLP
Scancell
LSE
HVO
Hvivo
LSE
ECR
Ecr Minerals
LSE
ZED
Zenova
LSE
CPX
Cap-xx
LSE
AAZ
Anglo Asian Mining
LSE
JLP
Jubilee Metals
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £903.96 only 361.58